Champions Oncology, Inc. (FRA:2I3)
Germany
· Delayed Price · Currency is EUR 5.05
+0.07 (1.41%)
At close: Dec 5, 2025
Champions Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | 2020 - 2016 |
| Net Income | 2.95 | 4.7 | -7.28 | -5.34 | 0.55 | 0.36 | Upgrade
|
| Depreciation & Amortization | 1.55 | 1.64 | 1.87 | 1.62 | 1.63 | 1.18 | Upgrade
|
| Other Amortization | - | - | - | 0.63 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.31 | 0.29 | 0.44 | - | -0 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.81 | - | - | Upgrade
|
| Stock-Based Compensation | 0.6 | 0.65 | 1.12 | 0.86 | 0.91 | 0.6 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.23 | -0.27 | 0.48 | 0.2 | 0.29 | 0.05 | Upgrade
|
| Other Operating Activities | 0.98 | 0.99 | 1.07 | 0.95 | 0.79 | 0.32 | Upgrade
|
| Change in Accounts Receivable | -0.24 | -1.44 | -1.99 | 1.31 | -2.82 | -2.27 | Upgrade
|
| Change in Accounts Payable | -0.77 | -1.75 | 0.47 | 2.47 | 0.97 | -1.25 | Upgrade
|
| Change in Unearned Revenue | 4.12 | 3.35 | -0.68 | 1.71 | 4.82 | 0.44 | Upgrade
|
| Change in Other Net Operating Assets | -1.6 | -0.79 | -1.61 | -1.24 | -0.64 | -1.13 | Upgrade
|
| Operating Cash Flow | 7.68 | 7.39 | -6.14 | 3.97 | 6.5 | -1.68 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -38.86% | - | - | Upgrade
|
| Capital Expenditures | -0.44 | -0.39 | -0.84 | -2.87 | -2.38 | -3.28 | Upgrade
|
| Other Investing Activities | - | - | - | - | - | 0.11 | Upgrade
|
| Investing Cash Flow | -0.44 | -0.39 | -0.84 | -2.87 | -2.38 | -3.17 | Upgrade
|
| Long-Term Debt Repaid | - | -0.15 | -0.15 | - | - | -0.17 | Upgrade
|
| Net Debt Issued (Repaid) | -0.15 | -0.15 | -0.15 | - | - | -0.17 | Upgrade
|
| Issuance of Common Stock | 0.34 | 0.32 | 0.25 | 0.09 | 0.21 | 1.37 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.63 | -0.07 | - | - | Upgrade
|
| Financing Cash Flow | 0.19 | 0.17 | -0.53 | 0.01 | 0.21 | 1.2 | Upgrade
|
| Net Cash Flow | 7.43 | 7.17 | -7.5 | 1.11 | 4.32 | -3.66 | Upgrade
|
| Free Cash Flow | 7.24 | 7 | -6.97 | 1.1 | 4.11 | -4.96 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -73.26% | - | - | Upgrade
|
| Free Cash Flow Margin | 12.73% | 12.29% | -13.90% | 2.04% | 8.38% | -12.09% | Upgrade
|
| Free Cash Flow Per Share | 0.51 | 0.49 | -0.52 | 0.08 | 0.29 | -0.34 | Upgrade
|
| Levered Free Cash Flow | 6.46 | 5.4 | -4.2 | 2.88 | 3.86 | -5.35 | Upgrade
|
| Unlevered Free Cash Flow | 6.48 | 5.41 | -4.18 | 2.88 | 3.86 | -5.35 | Upgrade
|
| Change in Working Capital | 1.51 | -0.62 | -3.82 | 4.24 | 2.34 | -4.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.